艾德生物：2025年前三季度归属于上市公司股东的净利润同比增长15.50%

Core Insights - The company reported a revenue of 865,632,981.04 yuan for the first three quarters of 2025, representing a year-on-year growth of 2.08% [2] - The net profit attributable to shareholders of the listed company was 262,505,939.10 yuan, showing a year-on-year increase of 15.50% [2] Financial Performance - Revenue for the first three quarters of 2025: 865.63 million yuan [2] - Year-on-year revenue growth: 2.08% [2] - Net profit for the first three quarters of 2025: 262.51 million yuan [2] - Year-on-year net profit growth: 15.50% [2]